胃肠道控制的二糖酸盐自组装颗粒增强了福可桑丁口服生物利用性,改善了视觉敏感性
Hailan Wang1, Liyuan Ma1, Jiabao Huang1
1College of Ocean Food and Biological Engineering, Jimei University, Xiamen, Fujian, 361021, People's Republic of China.
International journal of biological macromolecules
|January 21, 2026
概括
一种新的纳米复合物增强了海洋化合物富可桑 (FX) 的传递,改善了低光视力. 这一突破为使用天然生物活性化合物来提高视觉表现提供了一个有希望的策略.
科学领域:
- 海洋生物学 海洋生物学
- 生物材料科学 生物材料科学
- 眼科医生 眼科 眼科
背景情况:
- 有效地将营养物质输送到眼部组织对于视觉功能至关重要,特别是在低光条件下.
- 富可丁 (FX) 是一种海洋类胡卜素,具有视力保护的潜力,但其生物可用性和向性不佳.
- 现有的方法在有效地向眼睛输送营养物质方面面临挑战.
研究的目的:
- 开发富可丁 (FX) 的先进输送系统,以提高其生物可用性和眼球向性.
- 研究一种新型三元组合纳米复合物的有效性,以改善视觉敏感性.
- 探索海洋生物活性化合物的视力增强潜力.
主要方法:
- 一个三重组分纳米复合物 (FUC-BSA-DG-FX) 通过使用富可伊丹 (FUC),牛血清白蛋白 (BSA) 和二糖酸盐 (DG) 合成.
- 在体外评估中评估了FX封装,载荷能力,释放概况和生物可访问性.
- 在小鼠体内研究测量了血清和肝脏中的FX积累,眼睛代谢物丰富以及电网红图 (ERG) 反应.
主要成果:
- 该FUC-BSA-DG-FX纳米复合体表现出高的FX封装和持续释放,显著增强了肠道保留和生物可访问性.
- 在体内研究显示,与自由FX相比,小鼠血清 (6.59倍) 和肝脏 (22.81倍) 的FX水平显著增加.
- 电视网膜图评估显示,光视和光视视觉反应显著改善,这表明神经激活和视网膜功能得到了增强.
结论:
- 开发的纳米架构策略有效地提供功能营养素,特别是富可桑,以提高视觉性能.
- 这种方法提供了一种有前途的方法,可以使用海洋生物活性化合物来增强视力.
- 该研究强调了纳米技术在克服治疗化合物的生物可用性挑战方面的潜力.
相关概念视频
Bioavailability Enhancement: Drug Solubility Enhancement
229
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
229
Bioavailability Enhancement: Drug Permeability Enhancement
194
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
194
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
198
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
198
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
203
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
203
Precipitate Formation and Particle Size Control
6.3K
In precipitation gravimetry, the precipitating agent should react specifically or selectively with the analyte. While a specific reagent reacts with the analyte alone, a selective reagent can react with a limited number of chemical species.
The obtained precipitate should be either a pure substance of known composition or easily converted to one by a simple process, such as ignition or drying. In addition, the precipitate should be insoluble and easily filterable. In general, filterability...
The obtained precipitate should be either a pure substance of known composition or easily converted to one by a simple process, such as ignition or drying. In addition, the precipitate should be insoluble and easily filterable. In general, filterability...
6.3K
Bioavailability Study Design: Absolute Versus Relative Bioavailability
318
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
318


